Nurexone Biologic Inc (NRXBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 1,484 | 1,285 | 1,320 | 920 | -1,063 |
| Operating Income | -1,484 | -1,285 | -1,320 | -920 | 1,063 |
| Interest Expense | 50 | 2 | 21 | 8 | 15 |
| Other Income | -12 | 37 | 16 | 6 | -40 |
| Pre-tax Income | -1,546 | -1,250 | -1,325 | -922 | 1,008 |
| Net Income Continuous | -1,546 | -1,250 | -1,325 | -922 | 1,008 |
| Net Income | $-1,546 | $-1,250 | $-1,325 | $-922 | $1,008 |
| EPS Basic Total Ops | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 |
| EPS Basic Continuous Ops | -0.02 | -0.02 | -0.02 | -0.02 | 0.03 |
| EPS Diluted Total Ops | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 |
| EPS Diluted Continuous Ops | -0.02 | -0.02 | -0.02 | -0.02 | 0.03 |
| EPS Diluted Before Non-Recurring Items | -0.02 | -0.06 | -0.02 | N/A | N/A |
| EBITDA(a) | $-1,445 | $-1,267 | $-1,307 | $-905 | $1,066 |